Founded by research scientists in 1999, Cell Signaling Technology (CST) is a private, family-owned company active in applied systems biology research, particularly as it relates to cancer. Understanding the importance of using antibodies with high levels of specificity and consistency, CST scientists produce, validate and support all their antibodies in-house.